Early PSA levels after prostate surgery and cancer outcomes
Part of Cancer, Kidney & urinary clinical trials.
This study looks at how PSA (a blood marker) levels measured shortly after prostate removal surgery can predict whether cancer comes back. Researchers hope this helps doctors identify patients who may need closer monitoring or additional treatment after surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a biological male
- You have been diagnosed with prostate cancer (confirmed by biopsy or imaging)
- You have never received any prostate cancer treatment before
- You are planning to have your prostate surgically removed (open, laparoscopic, or robotic surgery)
- You do not have signs that cancer has spread to other parts of your body
- You will not receive chemotherapy or radiation before or after your surgery
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how PSA levels in drainage fluid change after prostate removal surgery to predict outcomes. It may help doctors understand your recovery and future risk.
This study looks at factors that can predict whether prostate cancer will come back in the 10 years after robot-assisted prostate removal surgery, and how well bladder control (urinary continence) recovers. It helps doctors understand which patients might do better long-term.
This trial tests a PET scan (flotufolastat F 18) to find tiny prostate cancer cells in men whose PSA is very low but still rising after prostate removal. It may help guide further treatment decisions.
This study looks at men with early-stage prostate cancer who had robotic surgery to remove the prostate. It aims to find which factors predict if the cancer might come back, helping doctors plan better follow-up care.
This trial studies whether testosterone levels before and around radical prostate surgery affect cancer control and sexual/physical recovery. It may help doctors understand who benefits from testosterone replacement and who should not.
This study tests a tailored (personalized) radiation plan for men whose PSA (“prostate blood test”) rises after prostate surgery but who have no detectable spread on scans. It may help control cancer growth by targeting the right area based on your situation.
Hear when a new Prostate Cancer (Post Prostatectomy) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.